Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Naba Alsaha Medical Services CoSAU:9546 55 Return-on-Tangible-Asset is 7.42% as of Dec. 2025, which is 55% below its 10-year median of 16.57. GuruFocus rates SAU:9546 with a GF Score™ of 55/100 and a GF Value™ of ﷼42.56 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 680 Healthcare Providers & Services companies, Naba Alsaha Medical Services Co ranks better than 73.82% on this metric.
The historical rank and industry rank for Naba Alsaha Medical Services Co's Return-on-Tangible-Asset or its related term are showing as below:
SAU:9546'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 7.33 Med: 16.57 Max: 23.76
Current: 7.95
During the past 5 years, Naba Alsaha Medical Services Co's highest Return-on-Tangible-Asset was 23.76%. The lowest was 7.33%. And the median was 16.57%.
SAU:9546's Return-on-Tangible-Asset is ranked better than 73.82% of 680
companies
in the Healthcare Providers & Services industry
Industry Median: 2.595
vs SAU:9546: 7.95
Naba Alsaha Medical Services Co (SAU:9546) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Naba Alsaha Medical Services Co Return-on-Tangible-Asset Related Terms
Naba Alsaha Medical Services Co Return-on-Tangible-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Naba Alsaha Medical Services Co Return-on-Tangible-Asset Chart
SAU:9546 vs HCA, THC, DVA: Return-on-Tangible-Asset Comparison
For the Medical Care Facilities subindustry, Naba Alsaha Medical Services Co's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Naba Alsaha Medical Services Co Return-on-Tangible-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Naba Alsaha Medical Services Co's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Naba Alsaha Medical Services Co's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Dec. 2025) net income data.
What does a Return-on-Tangible-Asset of 7.42% mean?
Naba Alsaha Medical Services Co (SAU:9546) has a Return-on-Tangible-Asset of 7.42% as of Dec. 2025. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Naba Alsaha Medical Services Co and its competitors. This is 55% below median its historical median of 16.57. Over the past decade, Naba Alsaha Medical Services Co's Return-on-Tangible-Asset has ranged from 7.33 to 23.76. According to the industry distribution chart, Naba Alsaha Medical Services Co ranks #178 out of 680 companies in the Healthcare Providers & Services industry, placing it in the top 26.2%.
Is Naba Alsaha Medical Services Co's Return-on-Tangible-Asset too high?
Naba Alsaha Medical Services Co's current Return-on-Tangible-Asset of 7.42% is 55% below median its 10-year median of 16.57. Over the past 10 years, this metric has ranged from a low of 7.33 to a high of 23.76. The Healthcare Providers & Services industry median Return-on-Tangible-Asset is 2.60. Naba Alsaha Medical Services Co's value of 7.42% is 185.9% above this industry median. Based on the distribution chart, Naba Alsaha Medical Services Co ranks #178 out of 680 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Naba Alsaha Medical Services Co has a GF Score™ of 55/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Naba Alsaha Medical Services Co's Return-on-Tangible-Asset compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Naba Alsaha Medical Services Co ranks #178 out of 680 companies for Return-on-Tangible-Asset. This puts Naba Alsaha Medical Services Co in the upper half of its industry. The industry median Return-on-Tangible-Asset is 2.60. Naba Alsaha Medical Services Co's value of 7.42% is 185.9% above this benchmark. Historically, Naba Alsaha Medical Services Co's own Return-on-Tangible-Asset has ranged from 7.33 to 23.76 over the past decade. While the company's 10-year median is 16.57 vs. the industry median of 2.60, Naba Alsaha Medical Services Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.60, based on 680 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Naba Alsaha Medical Services Co's current Return-on-Tangible-Asset of 7.42% is 185.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Naba Alsaha Medical Services Co and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Naba Alsaha Medical Services Co's current Return-on-Tangible-Asset is 7.42%, which is 55% below median its own 10-year median of 16.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Naba Alsaha Medical Services Co stock overvalued right now?
Based on GuruFocus' analysis, Naba Alsaha Medical Services Co (SAU:9546) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼42.56, compared to a current price of ﷼20.27 — trading 52.4% below its estimated fair value. The current Return-on-Tangible-Asset is 7.42%, which is 55% below median its 10-year median of 16.57 and 185.9% above the Healthcare Providers & Services industry median of 2.60. Naba Alsaha Medical Services Co's overall GF Score™ is 55/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Naba Alsaha Medical Services Co (SAU:9546), the current Return-on-Tangible-Asset is 7.42% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Naba Alsaha Medical Services Co (SAU:9546) Overvalued in 2026?
Based on GuruFocus' analysis, Naba Alsaha Medical Services Co stock appears to be undervalued.
The current stock price of ﷼20.27 is trading 52.4% below its estimated GF Value™ of ﷼42.56.
GuruFocus considers Naba Alsaha Medical Services Co to be Significantly Undervalued.
Key valuation signals for SAU:9546:
Return-on-Tangible-Asset: 7.42% (55% below median its 10-year median of 16.57)
GF Value™: ﷼42.56 vs. price of ﷼20.27 (52.4% below fair value)
Industry Position: 185.9% above the Healthcare Providers & Services median (#178 of 680)
No single metric tells the full story. See the SAU:9546 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Naba Alsaha Medical Services Co is engaged in the medical operation of private and government hospitals, health facilities, and hospital-related activities. It operates and manages Al-Zahraa Hospital, Manarat Al-Haramain Pharmacy, and the Nabaa Al-Saha branch for the practice of maintenance work and the operation of buildings. Geographically, it operates in the Kingdom of Saudi Arabia.
55GF Score
Get the complete analysis for SAU:9546
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:9546 has been successfully added to your 
